Fixing the antimicrobial market

CGD’s working group, A New Grand Bargain to Improve the Antimicrobial Market for Human Health, explores how to improve the market for antimicrobials and increase access, stewardship, and innovation, particularly in low- and middle-income countries.

More from the Series

Blog Post

Combatting AMR in India and Brazil: Policy Proposals to Improve Antimicrobial Access, Innovation, and Stewardship

May 18, 2023
Today we launched two country case studies examining policy proposals to improve antimicrobial procurement in India and Brazil (versão em português). These studies are outputs of CGD’s working group on antimicrobial procurement in low- and middle-income countries (LMICs), which is developing recomme...
Blog Post

G7 Investments in New Antibiotics Would Pay Off Big—For Everyone

December 08, 2022
The world desperately needs new antibiotics—and finally, the G7 is ready match commitments with action. We already found that the US would pay $17.9 billion over 30 years but save 383,000 American lives and harvest $495 billion in value. What would be the benefits to other members of the G7, and who...
Blog Post

The World Needs New Antibiotics. A Proposed US Program to Develop Them Would Pay Off 28:1

November 15, 2022
Congress has excellent legislation on the docket that would protect American citizens, yield huge returns, and create a safer, healthier world. We encourage the US Congress to urgently finance and authorize the PASTEUR Act, leveraging American ingenuity to boost our shared health future.
Blog Post

WASHing Away Resistance: The UK Can and Should Play a Leading Role in the Campaign to Improve Water, Sanitation and Hygiene

October 31, 2022
To reduce the threat of antimicrobial resistance, the UK must increase investment in water, sanitation and hygiene (wash) overseas.